Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Outset Medical (Nasdaq: OM) announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 4:30 p.m. PT. A live webcast and archived replay will be available in the Investors section of Outset Medical's website at https://investors.outsetmedical.com/.
This presentation offers investors a scheduled opportunity to hear company updates directly from management and access a recorded webcast for later review.
Positive
- None.
Negative
- None.
News Market Reaction – OM
In the Jan 6 session, OM gained 12.89%, reflecting a significant positive market reaction. Argus tracked a peak move of +7.5% during that session. Our momentum scanner triggered 22 alerts that day, indicating elevated trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 10 | Quarterly results | Neutral | +0.1% | Q3 2025 results with modest growth and lowered full‑year revenue guidance. |
| Nov 05 | Clinical outcomes data | Positive | -6.0% | New research from 1M+ Tablo treatments showing improved safety and satisfaction. |
| Nov 05 | Conference appearance | Neutral | -1.6% | Planned presentation at the 2025 Stifel Healthcare Conference with webcast access. |
| Oct 27 | Earnings preview | Neutral | -1.2% | Announcement of timing and access details for Q3 2025 earnings release and call. |
| Sep 03 | Commercial collaboration | Positive | +0.2% | Collaboration with Northwest Kidney Centers to expand home hemodialysis using Tablo. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news—earnings, collaborations, and conference appearances—has generally produced modest price reactions, with no large sustained moves following announcements.
Over the past few months, Outset Medical has reported Q3 2025 results with revenue of $29.4M and revised full‑year guidance, highlighted favorable real‑world research from over 1 million Tablo treatments, announced a collaboration to expand home hemodialysis where 20% of patients are treated at home, and participated in healthcare conferences. This J.P. Morgan appearance continues a pattern of investor‑facing updates and clinical/commercial visibility efforts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare conference on Wednesday, January 14, 2026, at 4:30 p.m. Pacific time.
A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.
Contact
Jim Mazzola
Vice President, Investor Relations
jmazzola@outsetmedical.com
